My Treatment Approach: Optimizing Treatment for Chronic GVHD - Episode 2
Navigating Chronic GVHD: Phases of Pathophysiology and Best Practices in Patient Monitoring
Medical experts discuss navigating chronic GVHD.
Video Player is loading.
Video content above is prompted by the following:
- Dr Holtan: Please address the 3 phases of pathophysiology of cGVHD (early inflammation, chronic inflammation and dysregulated immunity, and aberrant repair and fibrosis) and the interplay between them.
How does inflammation affect different organs? And fibrosis?
- Dr Ali:After confirmed diagnosis, please share your monitoring routine for patients with cGVHD.
- Are there certain symptom scores (eg, Lee skin symptom score) that are associated with better clinical outcomes?
- How do you share responsibility across subspecialty to monitor patients? Or other HCPS?
Related Content:
